Exclusive collaboration and co-development agreement for NTCD-M3 with Sebela Pharmaceuticals® worth up to $570m plus royalties
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://pdf.dfcfw.com/pdf/H22_AN202302241583711841_1.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts: